Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03526822 : Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Patient, male or female, aged 18 years or over

- Imaging suggestive of glioblastoma

- Patient eligible for excision surgery (partial, subtotal or macroscopically complete)

- Candidate for concomitant and adjuvant radiotherapy chemotherapy (Stupp protocol)

- Patient having signed an informed consent

- Patient having undergone a preoperative MRI

Exclusion Criteria:

- Existence of a contraindication to the MRI

- Nonoperable lesion

- History of radiotherapy and / or chemotherapy for this lesion

- Scalability of a low grade lesion

- Person in emergency situation, a legal person of legal age (guardianship, guardianship
or legal guardianship), or unable to express his or her consent

- No affiliation to a social security scheme (beneficiary or beneficiary)

- Pregnant or lactating woman
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03526822      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740